**Core Concept**
Hirsutism in PCOD is characterized by excessive hair growth due to androgen excess. The treatment aims to reduce androgen levels, block androgen effects, or prevent hair growth. Various pharmacological agents are used to manage hirsutism, but some have contraindications or are ineffective in PCOD patients.

**Why the Correct Answer is Right**
In PCOD patients with hirsutism, certain medications are contraindicated due to their androgenic or estrogenic effects. For instance, anabolic steroids are androgenic and can exacerbate hirsutism. Similarly, testosterone replacement therapy is contraindicated in women with hirsutism, as it can increase androgen levels and worsen symptoms.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because anabolic steroids are not typically used to treat hirsutism in PCOD. Instead, they can worsen symptoms due to their androgenic effects.
**Option B:** This option is incorrect because testosterone replacement therapy is contraindicated in women with hirsutism, as it can increase androgen levels and worsen symptoms.
**Option C:** This option is incorrect because corticosteroids are not directly related to the treatment of hirsutism in PCOD. They may be used to manage other symptoms, such as inflammation.
**Option D:** This option is incorrect because this is a common medication used to treat hirsutism in PCOD, not a contraindicated one.

**Clinical Pearl / High-Yield Fact**
When managing hirsutism in PCOD, it's essential to choose medications that specifically target androgen excess or hair growth. For example, spironolactone is a potassium-sparing diuretic that also blocks androgen receptors, while flutamide is an anti-androgen that can help reduce hirsutism symptoms.

**Correct Answer:** B. Testosterone replacement therapy